Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Long-Term Debt Repayments (2018 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $600405.0 as the latest value for Q4 2021.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $600405.0 in Q4 2021 year-over-year; TTM through Dec 2022 was $506498.0, a 12.04% decrease, with the full-year FY2021 number at $705405.0, changed N/A from a year prior.
  • Long-Term Debt Repayments was $600405.0 for Q4 2021 at Creative Medical Technology Holdings, up from -$93907.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $600405.0 in Q4 2021 to a low of -$93907.0 in Q3 2021.
  • A 3-year average of $146900.4 and a median of $118800.0 in 2019 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 20937.5% in 2019; the steepest drop was 88.02% in 2019.
  • Creative Medical Technology Holdings' Long-Term Debt Repayments stood at $215494.0 in 2018, then tumbled by 67.84% to $69300.0 in 2019, then surged by 766.39% to $600405.0 in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Long-Term Debt Repayments are $600405.0 (Q4 2021), -$93907.0 (Q3 2021), and $69300.0 (Q4 2019).